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a b s t r a c t
INTRODUCTION: Pseudopapillary tumors (PPT) of the pancreas are very rare, comprising 0.3–2.7% of
all pancreatic tumors, and they occur mostly in young women. Generally, they are benign, but in rare
cases they can enlarge, invade adjacent organs, and metastasize distantly. Radiological assessments and
biochemical markers are important for diagnosing tumor characteristics. The main treatment is tumor
resection.
PRESENTATIONOF CASE:An 18-year-old female was referred to our department suffering from abdominal
discomfort andupperquadrant abdominal pain. Abdominal computed tomography (CT) revealeda6-×5-
cm mass between the pancreatic head and right adrenal gland (Fig. 1). The histological assessment was
a solid PPT of the pancreas with intact surgical borders.
DISCUSSION: PPT are very rare, comprising approximately 5% of cystic pancreatic tumors and ∼1% of
exocrine pancreatic neoplasms and present mainly during the second and third decades of life. PPTs are
usually indolent tumors. As such, they tend to produce vague nonspeciﬁc symptoms or may be detected
incidentally on imaging. Complete surgical resection (R0) is the most effective therapy for PPT.
CONCLUSION: Although PPT is a very rare, benign tumor, it has the potential to metastasize to adjacent
and distant organs. Consequently, they should be detected early, so that they can be treated surgically
before malignant conversion.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/).
1. Introduction
Pseudopapillary tumors (PPT)of thepancreasarevery rare, com-
prising 0.3–2.7% of all pancreatic tumors [1–3]. The ﬁrst case was
described by Frantz in 1959, and thus PPT are referred to as Frantz
tumors [4]. The well-capsulated ovoid tumor is most common in
young women. Radiological images show heterogenic cystic, solid,
and calciﬁed components. Distant organ metastasis is rare. Only
10% of these tumors occur in males, although they may be more
aggressive in males [5]. Still, they are usually benign. The most
common symptoms of PPT are abdominal discomfort, abdominal
pain, and jaundice in rare cases; often they are asymptomatic [6–7].
Complete resection is the main treatment option for these tumors,
with a 95% 5-year survival rate [8]. Here, we present a completely
resectable PPT in a young female who was treated curatively.
∗ Corresponding author at: Inonu University, Faculty of Medicine, Department of
General Surgery, 44315 Malatya, Turkey. Tel.: +90 533 4233462.
E-mail address: abuzerdirican@hotmail.com (A. Dirican).
2. Case report
An18-year-old femalewas referred to our department suffering
from abdominal discomfort and upper quadrant abdominal pain.
She had no known disease that could have caused these symptoms,
nor a family history of illness. There was no tenderness or palpa-
ble mass on examination of the abdomen. Abdominal computed
tomography (CT) revealed a 6-×5-cm mass between the pancre-
atic head and right adrenal gland (Fig. 1). No metastasis to adjacent
organs was seen. Biochemical and tumor markers, including biliru-
bin, amylase, and lipase, were normal. The mass was removed
successfully without complications. There was no invasion of the
pancreas or duodenum, although it was adherent to the duodenum
and pancreatic head (Fig. 2). The patient was discharged 2 days
postoperatively with no complications. There were no complica-
tions or recurrence at the 3-month follow-up, and no chemo- or
radiotherapy was administered. The histological assessment was a
solid PPT of the pancreas with intact surgical borders.
3. Discussion
PPT are very rare, comprising approximately 5% of cystic pan-
creatic tumors and ∼1% of exocrine pancreatic neoplasms [9]. PPTs
http://dx.doi.org/10.1016/j.ijscr.2015.03.040
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/4.0/).
CASE REPORT – OPEN ACCESS
S. Karakas et al. / International Journal of Surgery Case Reports 10 (2015) 118–120 119
Fig. 1. 6×5 cm mass between pancreatic head, and right surrena.
are usually indolent tumors. As such, they tend to produce vague
nonspeciﬁc symptoms or may be detected incidentally on imag-
ing. As these lesions enlarge, they may then cause symptoms from
mass effect, such as vomiting and early satiety due to gastric out-
let obstruction. They present mainly during the second and third
decades of life [10]. The origin of solid PPT remains unclear. The
tumor cellsmoderately express the progesterone receptor, and this
tumor predominantly develops in women, suggesting an associa-
tion between female sex hormones and tumorigenesis [11–14].
The preoperative diagnosis is based primarily on radiological
assessment that includes abdominal CT and magnetic resonance
imaging (MRI). The PPT appears as an encapsulated, well-deﬁned
mass with central areas of calciﬁcation, necrosis, hemorrhage and
cystic degeneration [15]. Histological conﬁrmation is not neces-
sary, although in unresectable cases, ﬁne needle biopsy may be
performed with 62–70% preoperative accuracy [6,7,16].
Abdominal discomfort and pain are the most common symp-
toms [1,17]. Our patient presented with abdominal discomfort.
There are no pathognomonic features on blood investigations and
tumor markers are usually unremarkable.
PPT often develop in the pancreatic tail or head [2,18]. Most
metastases of these tumors are to the liver, lymph nodes, and peri-
toneum [2,17,18]. In our case, the tumor was separate from the
pancreas and duodenum, with no adjacent organ metastasis.
Fig. 2. Mass between duodenum and pancreatic head.
Histologically, the tumor is a heterogeneous mass that con-
tains hemorrhagic, cystic, necrotic, and calciﬁc components, and
is encapsulated with a sharp margin [2,11,19]. Since it is usually a
benign tumor of low malignant potential, the prognosis after sur-
gical resection is excellent. Complete surgical resection (R0) is the
most effective therapy for PPT [20]. Pancreatoduodenectomy, distal
pancreatectomy (with or without splenectomy), middle pancrea-
tectomy, or enucleation can be performed based on the location,
size, angioinvasion, and adjacent organ compromise. A classic or
pylorus-preserving pancreatoduodenectomy is indicated in cases
with tumors located in the pancreatic head or uncinate process.
Given the excellent prognosis, in patients with PPTs which involve
the superior mesenteric vein or/and portal vein, vein resection and
reconstruction should be considered. Distal pancreatectomy with
or without splenectomy can be performed for tumors located in
the pancreatic body or tail. For patients with tumors located in the
neckorbodyof thepancreas,withoutvessel involvement,weprefer
to perform middle pancreatectomy with distal pancreatojejunos-
tomy, preserving the rim of the head, the uncinate process, and the
tail portion. If the tumor isunresectable, radiotherapy is a treatment
option [3].
In conclusion, although PPT is a very rare, benign tumor, it
has the potential to metastasize to adjacent and distant organs.
Consequently, they should be detected early, so that they can be
treated surgically before malignant conversion. These tumors can
be resected easily because of their sharp margins. As in our case,
resection might be a curative treatment.
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Consent
Instant conﬁrmation forms is taken from the patient at the ﬁrst
application.
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